Evaluation of whole-body MRI in diagnostic accuracy of extrahepatic metastases in neuroendocrine tumors compared with the gold standard SSR-PET/CT
Recruiting
- Conditions
- D48Neoplasm of uncertain or unknown behaviour of other and unspecified sites
- Registration Number
- DRKS00026239
- Lead Sponsor
- Klinikum der Universität München, Campus Großhadern
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Clinically indicated MRI examination,
Existing clinical indication for liver MRI,
Patient's legal capacity, available written documentation of the informed consent interview and patient's consent to participate in the study,
Additional SSTR- PET-CT at the same time points (maximum 3 months time difference).
Exclusion Criteria
Impaired renal function (GFR < 30 ml/min/1.73m²),
Known intolerance of gadolinium-containing contrast agent,
Clinically or hemodynamically unstable patients,
Other contraindications to MRI examination (claustrophobia, pacemakers or other implants not compatible with 3T MRI, metal shards, etc.),
Pregnant women and nursing mothers
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diagnostic accuracy of whole-body MRI compared with PET/CT.
- Secondary Outcome Measures
Name Time Method Demographic data (age & sex) and histopathological data of primarius (proliferation index (ki-67) and grading (G1- G3).